FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH) HoFH is an inherited condition characterized by extremely high levels of low-densit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback